Asia-Pacific Market to Offer Significant Growth Opportunities for Players in the Electroceuticals Market in the Coming Years

By -

This report studies the global electroceuticals market for the forecast period of 2016 to 2021. This market is expected to reach USD 25.20 Billion by 2021 from USD 17.20 Billion in 2016, at a CAGR of 7.9%.

(EMAILWIRE.COM, February 06, 2019 ) The growth of the Electroceuticals Market is likely to be centered at the Asia-Pacific region due to rising adoption of neurostimulation in Japan, increasing cases of diabetes and rapidly aging population in China, increasing prevalence of hearing loss in Asia-Pacific region, increasing geriatric population & high diabetes prevalence in India, conferences on electroceutical devices in India and Australia, increasing prevalence of Parkinson’s Disease in Singapore, and regulatory approvals of cochlear implants in the Asia-Pacific region.

The aging population in Japan is growing at a significant rate, resulting into increase in the incidences of diseases like cancer, and various neurological diseases. The increasing incidences of these diseases, the demand for neurostimulation can be correspondingly expected to increase, boosting the electroceuticals market in Japan

The number of diabetics in China is expected in the coming years. ). The development of diabetic neuropathies among diabetics in China will drive the demand for transcutaneous electrical nerve stimulation and aid market growth in the region.

Read More Details | Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222053956

Moreover, due to the rapidly growing aging population in China, the prevalence of neurological disorders is expected to increase. As neuromodulation techniques are used to treat a large number of neurological disorders, including those linked to diabetes, the increase in diabetes prevalence and rising aging population in China, will be driving the market.

The growth in the geriatric population has resulted in an increased demand for neurological therapies in India. Moreover, India has the second-highest number of diabetics. Some patients suffering from diabetes develop diabetic neuropathies (nerve disorder) over a period of time, which can be treated with noninvasive neuromodulation techniques such as transcutaneous electrical nerve stimulation, driving the electroceuticals market in India.

Conferences establish a platform for the exchange of new advancements and technologies occurring in the field of electroceuticals/bioelectric medicine. They also offer players the opportunity to showcase their products and communicate with stakeholders, while helping scientists and researchers to exchange experiences. Recently held events in the Asia-Pacific region include the NSICON 2015, the 64th Annual Conference of the Neurological Society of India (NSI), was held in December 2015 in Hyderabad, India.

The 10th Annual Scientific Meeting of the Neuromodulation Society of Australia and New Zealand (NSANZ) was held in March 2015. The meet was conducted by the International Neuromodulation Society in Australia. The Western Pacific Regional Conference (WESPRAC) was organized in Singapore in December 2015, focused on research and development activities in the field of physiological acoustics, speech and hearing, and signal processing.

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=222053956

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more